University of Minnesota. Driven to Discover.
A total of 62.4% of patients taking tafenoquine were free of P vivax after 6 months.
Strains with key drug-resistance genes grew from 16% of samples in 2008 to 68% in 2013.
Both a promising vaccine and mass distribution of repellents failed to protect.
The findings add more evidence that resistance is common in parts of Cambodia.
Group discusses the narrow window now open for tackling artemisinin resistance.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.